Skip to main content
. 2024 Nov 16;22:304. doi: 10.1186/s12957-024-03575-3

Table 2.

Demographics and clinical characteristics of included studies

Outcomes Studies No. of patients WMD or OR 95% CI p-value Heterogeneity
UR/CC Chi2 df p-value I2 (%)
Age(years) (8) 304/454 0.78 [-1.07,2.62] 0.41 7.16 7 0.41 2
Gender(male) (11) 536/617 0.79 [0.60,1.04] 0.10 4.90 9 0.84 0
BMIa( kg/m2) (2) 69/65 -0.05 [-1.39,1.29] 0.94 0.89 1 0.34 0
Cirrhosis(yes) (7) 463/584 1.05 [0.79,1.41] 0.73 5.02 5 0.41 0
Major Hepatectomyb(yes) (12) 613/767 1.08 [0.85,1.38] 0.53 19.97 10 0.03 50
Malignant(yes) (8) 606/669 1.01 [0.71,1.45] 0.95 6.30 7 0.51 0

aBMI Body mass index

bMajor Hepatectomy(≥3 segments hepatectomy)